TaiRx, Inc. (6580.TWO)

TWD 26.9

(0.94%)

Revenue Summary of TaiRx, Inc.

  • TaiRx, Inc.'s latest annual revenue in 2023 was 5.08 Million TWD , down -26.59% from previous year.
  • TaiRx, Inc.'s latest quarterly revenue in 2024 Q1 was 132.5 Thousand TWD , down -94.76% from previous quarter.
  • TaiRx, Inc. reported a annual revenue of 6.92 Million TWD in annual revenue 2022, up 34.66% from previous year.
  • TaiRx, Inc. reported a annual revenue of 5.14 Million TWD in annual revenue 2021, up 53.05% from previous year.
  • TaiRx, Inc. reported a quarterly revenue of 132.5 Thousand TWD for 2024 Q1, down -94.76% from previous quarter.
  • TaiRx, Inc. reported a quarterly revenue of 13.5 Thousand TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of TaiRx, Inc. (2023 - 2019)

Historical Annual Revenue of TaiRx, Inc. (2023 - 2019)

Year Revenue Revenue Growth
2023 5.08 Million TWD -26.59%
2022 6.92 Million TWD 34.66%
2021 5.14 Million TWD 53.05%
2020 3.35 Million TWD 6.43%
2019 3.15 Million TWD 0.0%

Peer Revenue Comparison of TaiRx, Inc.

Name Revenue Revenue Difference
Bio Preventive Medicine Corp. 1.2 Million TWD -320.695%
Genomics BioSci & Tech. Co.,Ltd. 396.14 Million TWD 98.717%
Advagene Biopharma Co., Ltd. - TWD -Infinity%
Taiwan Bio Therapeutics Co., Ltd 85.47 Million TWD 94.054%
NaviFUS Corp. 22.48 Million TWD 77.394%
G&E Herbal Biotechnology Co., Ltd. 181.44 Million TWD 97.199%
Sinew Pharma Inc. - TWD -Infinity%
Lin BioScience, Inc. - TWD -Infinity%
TaiwanJ Pharmaceuticals Co., Ltd. 22.74 Million TWD 77.654%
Lumosa Therapeutics Co., Ltd. 56.91 Million TWD 91.071%
Anti-Microbial Savior BioteQ Co., Ltd 728 Thousand TWD -598.077%
SYN-TECH Chem. & Pharm. Co., Ltd. 1.11 Billion TWD 99.544%
AP Biosciences Inc 32.25 Million TWD 84.243%
Sunmax Biotechnology Co., Ltd. 1.68 Billion TWD 99.699%
RBC Bioscience Corporation 172.46 Million TWD 97.053%
Syngen Biotech Co.,Ltd. 1.83 Billion TWD 99.723%
EirGenix Inc. 1.02 Billion TWD 99.503%
Enimmune corporation 43.49 Million TWD 88.316%
Lukas Biomedical Inc. 231.83 Million TWD 97.808%
BRIM Biotechnology, Inc. 90 Thousand TWD -5546.667%
3D Global Biotech Inc. 20.63 Million TWD 75.37%
TaiMed Biologics Inc. 491.77 Million TWD 98.967%
Mycenax Biotech Inc. 652.62 Million TWD 99.221%
TCI GENE Inc. 333.85 Million TWD 98.478%
SynCore Biotechnology Co.,Ltd 20.19 Million TWD 74.837%
Oneness Biotech Co., Ltd. 86.78 Million TWD 94.144%
Eusol Biotech Co.,Ltd. - TWD -Infinity%
Feng Chi Biotech Corp. 180.57 Million TWD 97.186%
NeoCore Technology Co., Ltd. 64.72 Million TWD 92.149%
TWi Biotechnology, Inc. - TWD -Infinity%
Neith Corporation 39.9 Million TWD 87.264%
Sunny Pharmtech Inc. 428.82 Million TWD 98.815%
VBI 55.85 Million TWD 90.901%
Ever Supreme Bio Technology Co., Ltd 758.39 Million TWD 99.33%
GeneReach Biotechnology Corp. 225.46 Million TWD 97.746%
Shine-On BioMedical Co.,Ltd. 9.52 Million TWD 46.64%
CHO Pharma, Inc. - TWD -Infinity%
Andros Pharmaceuticals Co.,Ltd 805 Thousand TWD -531.304%
MegaPro Biomedical Co., Ltd 18 Thousand TWD -28133.333%
Visgeneer Inc. 147.99 Million TWD 96.566%
Greenyn Biotechnology Co., Ltd 800.51 Million TWD 99.365%
BioLASCO Taiwan Co., Ltd. 264.72 Million TWD 98.08%
Gwo Xi Stem Cell Applied Technology Co. , Ltd 141.17 Million TWD 96.4%
Sagittarius Life Science Corp 440.46 Million TWD 98.846%
BioGend Therapeutics Co., Ltd. 109.9 Million TWD 95.376%
GlycoNex Incorporation 2.54 Million TWD -99.921%
Medigen Biotechnology Corp. 1.15 Billion TWD 99.561%
Pharmosa Biopharm Inc. 314.5 Million TWD 98.384%
PharmaEngine, Inc. 767.66 Million TWD 99.338%
Intech Biopharm Corporation 25.84 Million TWD 80.338%
Taiwan Advance Bio-Pharmaceutical Inc. 315.98 Million TWD 98.392%
BiOptic Inc. 228.26 Million TWD 97.774%
TaiGen Biopharmaceuticals Holdings Limited 123.13 Million TWD 95.873%
Senhwa Biosciences, Inc. 1 Million TWD -408.2%
NatureWise Biotech & Medicals Corporation 160.14 Million TWD 96.827%
OBI Pharma, Inc. 41.54 Million TWD 87.769%
Savior Lifetec Corporation 1.05 Billion TWD 99.516%
Great Novel Therapeutics Biotech & Medicals 4.85 Million TWD -4.784%
Level Biotechnology Inc. 660.61 Million TWD 99.231%
Medigen Vaccine Biologics Corporation 389.62 Million TWD 98.696%
Meribank Biotech Co., Ltd 234.34 Million TWD 97.831%
Acepodia, Inc. 16.59 Million TWD 69.373%
Caliway Biopharmaceuticals Co., Ltd. 38.93 Million TWD 86.946%